Thirty-three researchers from across the globe visited the Bronfenbrenner Center for Translational Research last month to learn how to conduct research through community partnerships that will inform real-world practices and decisions.
Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a new study.
Every family in America has an immigration story. In a new anthology, Andrew Tisch and Mary Skafidas showcase a variety of voices whose own origin stories illustrate the rich fabric of cultures and backgrounds that comprise the United States.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults.
A year into Cornell’s Academic Integration Initiative, Gary Koretzky ’78 is relocating to Ithaca and taking on a new title to continue leading efforts to better promote, build and enhance collaborative research efforts across Cornell's campuses.
A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis.
